1. Targeting Strategies for the Combination Treatment of Cancer Using Drug Delivery Systems
    Janel Kydd et al, 2017, Pharmaceutics CrossRef
  2. An overview on the current status of cancer nanomedicines
    Nasimudeen R. Jabir et al, 2018, Current Medical Research and Opinion CrossRef
  3. Transferrin targeted liposomal 5-fluorouracil induced apoptosis via mitochondria signaling pathway in cancer cells
    Eskandar Moghimipour et al, 2018, Life Sciences CrossRef
  4. Multicellular Tumor Spheroids (MCTS) as a 3D In Vitro Evaluation Tool of Nanoparticles
    Hongxu Lu et al, 2018, Small CrossRef
  5. Transferrin and tocopheryl-polyethylene glycol-succinate dual ligands decorated, cisplatin loaded nano-sized system for the treatment of lung cancer
    Guobin Xu et al, 2018, Biomedicine & Pharmacotherapy CrossRef
  6. Critical Parameters for Particle-Based Pulmonary Delivery of Chemotherapeutics
    Ali Dabbagh et al, 2017, Journal of Aerosol Medicine and Pulmonary Drug Delivery CrossRef
  7. Development and optimization of methotrexate-loaded lipid-polymer hybrid nanoparticles for controlled drug delivery applications
    Nayab Tahir et al, 2017, International Journal of Pharmaceutics CrossRef
  8. Facilitating the Cellular Accumulation of Pt-Based Chemotherapeutic Drugs
    Ian Lambert et al, 2018, IJMS CrossRef
  9. Targeted Nanotherapeutics Encapsulating Liver X Receptor Agonist GW3965 Enhance Antiatherogenic Effects without Adverse Effects on Hepatic Lipid Metabolism in Ldlr−/− Mice
    Mikyung Yu et al, 2017, Adv. Healthcare Mater. CrossRef
  10. Antiproliferative and Apoptosis Triggering Potential of Paclitaxel-Based Targeted-Lipid Nanoparticles with Enhanced Cellular Internalization by Transferrin Receptors—a Study in Leukemia Cells
    Yang Dai et al, 2018, Nanoscale Res Lett CrossRef
  11. null
    S.P. Egusquiaguirre et al, 2016 CrossRef
  12. null
    Diana Sousa et al, 2019 CrossRef
  13. A mechanistic study of the effect of transferrin conjugation on cytotoxicity of targeted liposomes
    Eskandar Moghimipour et al, 2018, Journal of Microencapsulation CrossRef
  14. New insights into designing hybrid nanoparticles for lung cancer: Diagnosis and treatment
    Fatemeh Mottaghitalab et al, 2019, Journal of Controlled Release CrossRef
  15. null
    Devesh Kapoor et al, 2019 CrossRef
  16. Magnetic nanocarriers: Evolution of spinel ferrites for medical applications
    Mahnaz Amiri et al, 2019, Advances in Colloid and Interface Science CrossRef
  17. null
    Josef Jampílek et al, 2019 CrossRef
  18. Inhalable Nanostructures for Lung Cancer Treatment: Progress and Challenges
    A. Singh et al, 2019, CNANOM CrossRef
  19. Transferrin receptors-targeting nanocarriers for efficient targeted delivery and transcytosis of drugs into the brain tumors: a review of recent advancements and emerging trends
    Hira Choudhury et al, 2018, Drug Deliv. and Transl. Res. CrossRef
  20. Lipid-chitosan hybrid nanoparticles for controlled delivery of cisplatin
    Muhammad Muzamil Khan et al, 2019, Drug Delivery CrossRef
  21. Artemisinin-Based Smart Nanomedicines with Self-Supply of Ferrous Ion to Enhance Oxidative Stress for Specific and Efficient Cancer Treatment
    Yingping Luo et al, 2019, ACS Appl. Mater. Interfaces CrossRef
  22. Co-delivery of baicalein and doxorubicin by hyaluronic acid decorated nanostructured lipid carriers for breast cancer therapy
    Qian Liu et al, 2015, Drug Delivery CrossRef
  23. Dihydroartemisinin and transferrin dual-dressed nano-graphene oxide for a pH-triggered chemotherapy
    Lijuan Liu et al, 2015, Biomaterials CrossRef
  24. Effect of integrin receptor-targeted liposomal paclitaxel for hepatocellular carcinoma targeting and therapy.
    Liyu Chen et al, 2015, Oncol Lett CrossRef
  25. ‘Smartening’ anticancer therapeutic nanosystems using biomolecules
    Rebeca Núñez-Lozano et al, 2015, Current Opinion in Biotechnology CrossRef
  26. Lung cancer nanomedicine: potentials and pitfalls
    Deniz Ali Bölükbas et al, 2015, Nanomedicine CrossRef
  27. Multifunctional carbon dots as efficient fluorescent nanotags for tracking cells through successive generations
    Bharat Bhushan et al, 2016, J. Mater. Chem. B CrossRef
  28. null
    S. Alam et al, 2017 CrossRef
  29. Losartan loaded liposomes improve the antitumor efficacy of liposomal paclitaxel modified with pH sensitive peptides by inhibition of collagen in breast cancer
    Tai Xia et al, 2018, Pharmaceutical Development and Technology CrossRef
  30. Tumor-targeted nanomedicines for cancer theranostics
    Alexandra G. Arranja et al, 2017, Pharmacological Research CrossRef
  31. Novel transferrin modified and doxorubicin loaded Pluronic 85/lipid-polymeric nanoparticles for the treatment of leukemia: In vitro and in vivo therapeutic effect evaluation
    Baomin Zhu et al, 2017, Biomedicine & Pharmacotherapy CrossRef
  32. Novel nanoparticulate systems for lung cancer therapy: an updated review
    Asadullah Madni et al, 2017, Journal of Drug Targeting CrossRef
  33. null
    Rukkumani Rajagopalan et al, 2017 CrossRef
  34. Nanoparticles and targeted drug delivery in cancer therapy
    Behdokht Bahrami et al, 2017, Immunology Letters CrossRef
  35. Chemodrug delivery using integrin-targeted PLGA-Chitosan nanoparticle for lung cancer therapy
    Anish Babu et al, 2017, Sci Rep CrossRef
  36. Utilization of green formulation technique and efficacy estimation on cell line studies for dual anticancer drug therapy with niosomes
    Daulat Haleem Khan et al, 2019, International Journal of Pharmaceutics CrossRef
  37. Recent developments in functionalized polymer nanoparticles for efficient drug delivery system
    Srija Sur et al, 2019, Nano-Structures & Nano-Objects CrossRef
  38. Stepwise dual pH and redox-responsive cross-linked polypeptide nanoparticles for enhanced cellular uptake and effective cancer therapy
    Jing Qu et al, 2019, J. Mater. Chem. B CrossRef
  39. Targeted delivery of DOX by transferrin conjugated DSPE-PEG nanoparticles in leukemia therapy
    Zhigang Fang et al, 2019, International Journal of Polymeric Materials and Polymeric Biomaterials CrossRef
  40. null
    Harsh A. Joshi et al, 2019 CrossRef
  41. Three-dimensional tumor models: Promoting breakthroughs in nanotheranostics translational research
    Ana Katrina Mapanao et al, 2020, Applied Materials Today CrossRef
  42. null
    Mariana Tasso et al, 2020 CrossRef
  43. null
    Joanne M. Ramsey et al, 2020 CrossRef
  44. Efficient Gene Therapy of Pancreatic Cancer via a Peptide Nucleic Acid (PNA)‐Loaded Layered Double Hydroxides (LDH) Nanoplatform
    Zhiguo Yu et al, 2020, Small CrossRef
  45. Afatinib-loaded inhalable PLGA nanoparticles for localized therapy of non-small cell lung cancer (NSCLC)—development and in-vitro efficacy
    Rasha S. Elbatanony et al, 2020, Drug Deliv. and Transl. Res. CrossRef
  46. null
    Priya Shrivastava et al, 2020 CrossRef
  47. Inhaled nanoparticles—An updated review
    Tuangrat Praphawatvet et al, 2020, International Journal of Pharmaceutics CrossRef
  48. Polymer-hybrid nanoparticles: Current advances in biomedical applications
    Daniel Crístian Ferreira Soares et al, 2020, Biomedicine & Pharmacotherapy CrossRef
  49. Utilization of Polymer-Lipid Hybrid Nanoparticles for Targeted Anti-Cancer Therapy
    Ayeskanta Mohanty et al, 2020, Molecules CrossRef
  50. Targeted drug therapy in non-small cell lung cancer: Clinical significance and possible solutions-part II (role of nanocarriers)
    Khushwant S. Yadav et al, 2020, Expert Opinion on Drug Delivery CrossRef
  51. Distinct Proteins in Protein Corona of Nanoparticles Represent a Promising Venue for Endogenous Targeting – Part II: In vitro and in vivo Kinetics Study

    Aya Ahmed Sebak et al, 2020, IJN CrossRef
  52. null
    Anupam Sarma et al, 2020 CrossRef
  53. Cell membrane-derived vesicles for delivery of therapeutic agents
    Quoc-Viet Le et al, 2021, Acta Pharmaceutica Sinica B CrossRef
  54. Cytotoxicity of targeted PLGA nanoparticles: a systematic review
    Hock Ing Chiu et al, 2021, RSC Adv. CrossRef
  55. Development and In Vitro Characterization of Transferrin-Decorated Nanoemulsion Utilizing Hydrophobic Ion Pairing for Targeted Cellular Uptake
    Sergey Zaichik et al, 2021, J Pharm Innov CrossRef
  56. Lipid-polymer hybrid nanoparticles in cancer therapy: current overview and future directions
    Francesca Persano et al, 2021, Nano Ex. CrossRef
  57. Onco-Receptors Targeting in Lung Cancer via Application of Surface-Modified and Hybrid Nanoparticles: A Cross-Disciplinary Review
    Fakhara Sabir et al, 2021, Processes CrossRef
  58. Small extracellular vesicles in cancer
    Komal Abhange et al, 2021, Bioactive Materials CrossRef
  59. The impact of molecular tumor profiling on the design strategies for targeting myeloid leukemia and EGFR/CD44-positive solid tumors
    Nikola Geskovski et al, 2021, Beilstein J. Nanotechnol. CrossRef
  60. Multifunctional PLGA nanoparticles combining transferrin-targetability and pH-stimuli sensitivity enhanced doxorubicin intracellular delivery and in vitro antineoplastic activity in MDR tumor cells
    Laís E. Scheeren et al, 2021, Toxicology in Vitro CrossRef
  61. Exemestane encapsulated polymer-lipid hybrid nanoparticles for improved efficacy against breast cancer: optimization, in vitro characterization and cell culture studies
    Md Rizwanullah et al, 2021, Nanotechnology CrossRef
  62. Development and characterization of inhalable transferrin functionalized amodiaquine nanoparticles – Efficacy in Non-Small Cell Lung Cancer (NSCLC) treatment
    Vineela Parvathaneni et al, 2021, International Journal of Pharmaceutics CrossRef
  63. Dual-targeting SERS-encoded graphene oxide nanocarrier for intracellular co-delivery of doxorubicin and 9-aminoacridine with enhanced combination therapy
    Hui Chen et al, 2021, Analyst CrossRef
  64. Anthraquinone: a promising scaffold for the discovery and development of therapeutic agents in cancer therapy
    Supraja Siddamurthi et al, 2020, Future Medicinal Chemistry CrossRef
  65. Probing Transferrin Receptor Overexpression in Gastric Cancer Mice Models
    Madeeha Shahzad Lodhi et al, 2021, ACS Omega CrossRef
  66. Recent Advances in the Surface Functionalization of PLGA-Based Nanomedicines
    Mazen M. El-Hammadi et al, 2022, Nanomaterials CrossRef
  67. Phytochemical investigations and development of ethosomal gel with Brassica oleraceae L. (Brassicaceae) extract: An innovative nano approach towards cosmetic and pharmaceutical industry
    Palwasha Khan et al, 2022, Industrial Crops and Products CrossRef
  68. Synthesis of hyaluronic acid-grafted hollow mesoporous silica nanoparticles as nano-carriers for anticancer drug delivery
    Soroush Mirfakhraee et al, 2022, J Nanopart Res CrossRef
  69. null
    Reshu Virmani et al, 2022 CrossRef
  70. Alpha-Mangostin-Loaded Transferrin-Conjugated Lipid-Polymer Hybrid Nanoparticles: Development and Characterization for Tumor-Targeted Delivery
    Intouch Sakpakdeejaroen et al, 2022, The Scientific World Journal CrossRef
  71. Folate decorated lipid chitosan hybrid nanoparticles of 5-fluorouracil for enhanced anticancer efficacy against colon cancer
    Safiullah Khan et al, 2022, International Journal of Biological Macromolecules CrossRef
  72. Elevated expression of receptors for EGF, PDGF, transferrin and folate within murine and human lupus nephritis kidneys
    Sylvia Xie et al, 2022, Clinical Immunology CrossRef
  73. Corrole Nanoparticles for Chemotherapy of Castration-Resistant Prostate Cancer and as Sonodynamic Agents for Pancreatic Cancer Treatment
    Matan Soll et al, 2022, J. Med. Chem. CrossRef
  74. Emerging potential of 5-Fluorouracil-loaded chitosan nanoparticles in cancer therapy
    Tenzin Tsering Dongsar et al, 2023, Journal of Drug Delivery Science and Technology CrossRef
  75. null
    B. Patil et al, 2023 CrossRef
  76. null
    Zoe Hancox et al, 2023 CrossRef
  77. null
    Gholamali Farzi et al, 2023 CrossRef